BCAM
LLY icon

Boston Common Asset Management’s Eli Lilly LLY Stock Holding History

Boston Common Asset Management’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$27.1M Sell
22,557
-1,796
-7% -$1.84M 1.6% 12
2026
Q1 		$22.4M Sell
24,353
-2,875
-11% -$2.91M 1.44% 14
2025
Q4 		$29.3M Sell
27,228
-8,064
-23% -$7.71M 1.76% 11
2025
Q3 		$26.9M Sell
35,292
-471
-1% -$350K 0.75% 35
2025
Q2 		$27.9M Buy
35,763
+8,468
+31% +$6.58M 0.78% 36
2025
Q1 		$22.5M Buy
27,295
+3,267
+14% +$2.72M 0.68% 46
2024
Q4 		$18.5M Buy
24,028
+5,465
+29% +$4.53M 0.54% 67
2024
Q3 		$16.4M Buy
18,563
+8,106
+78% +$7.29M 0.43% 91
2024
Q2 		$9.47M Buy
10,457
+600
+6% +$480K 0.24% 128
2024
Q1 		$7.67M Sell
9,857
-247
-2% -$176K 0.18% 155
2023
Q4 		$5.89M Sell
10,104
-287
-3% -$168K 0.13% 189
2023
Q3 		$5.58M Buy
10,391
+4,253
+69% +$2.19M 0.13% 186
2023
Q2 		$2.88M Buy
+6,138
New +$2.57M 0.06% 236
2023
Q1 		– Sell
-2,825
Closed -$1.03M – 331
2022
Q4 		$1.03M Buy
2,825
+66
+2% +$23.4K 0.05% 162
2022
Q3 		$892K Buy
2,759
+35
+1% +$11.1K 0.05% 167
2022
Q2 		$883K Buy
2,724
+233
+9% +$69.9K 0.04% 178
2022
Q1 		$713K Sell
2,491
-298
-11% -$76.7K 0.03% 189
2021
Q4 		$770K Buy
2,789
+151
+6% +$38.3K 0.03% 185
2021
Q3 		$610K Buy
2,638
+6
+0.2% +$1.48K 0.03% 198
2021
Q2 		$604K Buy
2,632
+185
+8% +$37.2K 0.03% 204
2021
Q1 		$457K Buy
2,447
+27
+1% +$5.28K 0.03% 212
2020
Q4 		$409K Buy
+2,420
New +$361K 0.03% 209

Other funds holding LLY

Lilly Endowment
Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $202B AUM 37.79% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Boston Common Asset Management's LLY Position: Q2 2026 in Review

Boston Common Asset Management reduced its Eli Lilly (LLY) stake by 7.4% in Q2 2026, selling an estimated $1.84M and leaving 22,557 shares worth $27.1M. The position accounts for 1.6% of the portfolio, ranked #12.

Boston Common Asset Management first reported a position in LLY in Q4 2020 and has held it in 22 quarters since. The position peaked at $29.3M in Q4 2025. 4,618 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Boston Common Asset Management held 22,557 shares of Eli Lilly worth $27.1M as of Q2 2026.
  • Boston Common Asset Management sold 1,796 Eli Lilly shares in Q2 2026, an estimated $1.84M.
  • Eli Lilly made up 1.6% of Boston Common Asset Management's portfolio in Q2 2026, its #12 holding.
  • Boston Common Asset Management first reported a position in Eli Lilly in Q4 2020 and has held it in 22 quarters since.
  • Boston Common Asset Management's Eli Lilly position peaked at $29.3M in Q4 2025.
  • 4,618 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Boston Common Asset Management's 13F filing for Q2 2026, filed 21 Jul 2026.